Concertotm
Payments companies reported to CMS as associated with Concertotm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Concertotm, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Concertotm
These are the largest totals companies reported as associated with Concertotm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gary Siskin | Albany, NY | Vascular & Interventional Radiology | $44,503.23 |
| Gloria Salazar | Chapel Hill, NC | Vascular & Interventional Radiology | $35,890.12 |
| Jessica Stewart | Los Angeles, CA | Vascular & Interventional Radiology | $35,776.74 |
| Anuj Malhotra | Albany, NY | Vascular & Interventional Radiology | $27,629.45 |
| Antony Gayed | Greenville, SC | Vascular & Interventional Radiology | $16,577.40 |
| Guillermo Gonzalez-Araiza | Saint Louis, MO | Vascular & Interventional Radiology | $12,451.84 |
| Jeffrey Ramkaransingh | Indianapolis, IN | Vascular & Interventional Radiology | $11,380.63 |
| Charles Martin | Cleveland, OH | Vascular & Interventional Radiology | $10,726.89 |
| Suvranu Ganguli | Boston, MA | Vascular & Interventional Radiology | $9,840.92 |
| Dania Daye | Framingham, MA | Vascular & Interventional Radiology | $9,551.93 |
Prescribed Concertotm?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.